Literature DB >> 6316395

Early postnatal chlordiazepoxide administration: permanent behavioural effects in the mature rat and possible involvement of the GABA-benzodiazepine system.

E Coen, M P Abbracchio, W Balduini, R Cagiano, V Cuomo, G Lombardelli, G Peruzzi, M C Ragusa, F Cattabeni.   

Abstract

The long term behavioural and biochemical effects of chronic chlordiazepoxide treatment during the period of neuronal maturation in the rat have been investigated. The administration to lactating mothers of chlordiazepoxide at very low doses (0.22 and 2.6 mg/kg) in their drinking water affects both behavioural and biochemical parameters in offspring at 60 days of age and undrugged since weaning. A deficit in the acquisition of the conditioned avoidance response in treated rats was observed, although no significant difference in spontaneous locomotor activity between control and treated rats was found. 3H-Flunitrazepam binding sites in cerebral cortex and hippocampus were decreased by the treatment, whereas no change was detected in cerebellum. Moreover, 3H-muscimol binding sites increased in hippocampus with no changes in cerebral cortex and cerebellum. According to the different regional distribution of benzodiazepine type 1 and type 2 receptors, we suggest that type 2 receptors are selectively affected by the treatment, and that the GABAergic receptor system is also permanently altered by administration of chlordiazepoxide during early postnatal life.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6316395     DOI: 10.1007/bf00427275

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

Review 1.  New concepts on the mechanism of action of benzodiazepines.

Authors:  E Costa; A Guidotti; C C Mao; A Suria
Journal:  Life Sci       Date:  1975-07-15       Impact factor: 5.037

2.  Muscimol binding in rat brain: association with synaptic GABA receptors.

Authors:  K Beaumont; W S Chilton; H I Yamamura; S J Enna
Journal:  Brain Res       Date:  1978-06-09       Impact factor: 3.252

3.  Neurochemical aspects of the ontogenesis of GABAnergic neurons in the rat brain.

Authors:  J T Coyle; S J Enna
Journal:  Brain Res       Date:  1976-07-23       Impact factor: 3.252

4.  No changes in rat benzodiazepine receptors after withdrawal from continuous treatment with lorazepam and diazepam.

Authors:  C Braestrup; M Nielsen; R F Squires
Journal:  Life Sci       Date:  1979-01-22       Impact factor: 5.037

5.  Ontogenetic changes in GABA modulation of brain benzodiazepine binding.

Authors:  P Mallorga; M Hamburg; J F Tallman; D W Gallager
Journal:  Neuropharmacology       Date:  1980-04       Impact factor: 5.250

6.  The postnatal development of the benzodiazepine receptor in the cerebral cortex and cerebellum of the rat.

Authors:  J M Candy; I L Martin
Journal:  J Neurochem       Date:  1979-02       Impact factor: 5.372

7.  The benzodiazepine receptor: its development and its modulation by gamma-aminobutyric acid.

Authors:  J W Regan; W R Roeske; H I Yamamura
Journal:  J Pharmacol Exp Ther       Date:  1980-01       Impact factor: 4.030

8.  A preliminary test battery for the investigation of the behavioral teratology of selected psychotropic drugs.

Authors:  R E Butcher; C V Vorhees
Journal:  Neurobehav Toxicol       Date:  1979

9.  Enduring behavioural and biochemical effects in the adult rat after prolonged postnatal administration of haloperidol.

Authors:  V Cuomo; R Cagiano; E Coen; I Mocchetti; F Cattabeni; G Racagni
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

10.  The effect of prenatal exposure to diazepam on aspects of postnatal development and behavior in rats.

Authors:  N Gai; V E Grimm
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

View more
  1 in total

Review 1.  Psychoactive drug exposure during breastfeeding: a critical need for preclinical behavioral testing.

Authors:  Irving Zucker
Journal:  Psychopharmacology (Berl)       Date:  2018-03-16       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.